Experimental hyperhomocysteinemia disturbs bone metabolism in rats

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 67, Issue 7, 2007, Pages 748-756

  Ozdem, S ^a   Samanci, N ^a   Tasatargil A ^a   Yildiz, A ^a   Sadan, G ^a   Donmez, L ^a   Herrmann, M ^b  

^a AKDENIZ UNIVERSITY   (Turkey)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

Biological markers; Bone; Bone density; Homocysteine; Hyperhomocysteinemia; Osteoporosis; Rats

Indexed keywords

AMINO TERMINAL TELOPEPTIDE; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; HYDROXYPROLINE; METHIONINE; OSTEOCALCIN;

ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; BONE DENSITY; BONE METABOLISM; BONE TURNOVER; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FRACTURE; HYPERHOMOCYSTEINEMIA; NONHUMAN; OSTEOLYSIS; PRIORITY JOURNAL; RAT; URINALYSIS;

ANIMALS; BODY WEIGHT; BONE AND BONES; BONE DENSITY; BONE RESORPTION; COLLAGEN TYPE I; CREATINE; FEMALE; FOLIC ACID; HOMOCYSTEINE; HYDROXYPROLINE; HYPERHOMOCYSTEINEMIA; METHIONINE; OSTEOCALCIN; OSTEOGENESIS; PEPTIDES; RATS; RATS, WISTAR; VITAMIN B 12;

RATTUS;

EID: 35648982543     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.1080/00365510701342088     Document Type: Article

References (35)

1. Consensus Development Conference: Diagnosis, prophylaxis and treatment of osteoporosis. Am J Med 1993;94:646-50.
2. NIH: NIH Consensus Development Panel on Osteoporosis, Prevention, Diagnosis, and Therapy. J Am Med Assoc 2001;285:785-95.
3. Boonen S, Autier P, Barette M, Vanderschueren D, Lips P, Haentjens P. Functional outcome and quality of life following hip fracture in elderly women: A prospective controlled study. Osteoporos Int 2004;15:87-94.
4. Chapuy MC, Arlot ME, Duboeuf F, Brun J, Crouzet B, Arnaud S, et al. Vitamin D3 and calcium to prevent hip fractures in elderly women. N Engl J Med 1992;327:1637-42.
5. Herrmann M, Widmann T, Herrmann W. Homocysteine: a newly recognised risk factor for osteoporosis. Clin Chem Lab Med 2005;43:1111-17.
6. Herrmann M, Taban-Shomal O, Müller S, Gunter L, Hübner U, Böhm M, et al. Hyperhomocysteinemia: the biochemical link between a weak heart and brittle bones? Clin Lab 2006;52:137-47.
7. McLean RR, Jacques PF, Selhub J, Tucker KL, Samelson EJ, Broe KE, et al. Homocysteine as a predictive factor for hip fracture in older persons. N Engl J Med 2004;350:2042-9.
8. van Meurs JB, Dhonukshe-Rutten RA, Pluijm SM, van Der Klift M, de Jonge R, Lindemans J, et al. Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med 2004;350:2033-41.
9. Dhonukshe-Rutten RAM, Pluijm SMF, de Groot LCPGM, Lips P, Smit JH, van Staveren WA. Homocysteine and vitamin B12 status relate to bone turnover markers, broadband ultrasound attenuation, and fractures in healthy elderly people. J Bone Miner Res 2005;20:921-9.
10. Masse PG, Boskey AL, Ziv I, Hauschka P, Donovan SM, Howell DS, et al. Chemical and biomechanical characterization of hyperhomocysteinemic bone disease in an animal model. BMC Musculoskelet Disord 2003;4:2.
11. Herrmann M, Widmann T, Colaianni G, Colucci S, Zallone A, Herrmann W. Increased osteoclast activity in the presence of increased homocysteine concentrations. Clin Chem 2005;51:2348-53.
12. Koh JM, Lee YS, Kim YS, Kim DJ, Kim HH, Park JY, et al. Homocysteine enhances bone resorption by stimulation of osteoclast formation and activity through increased intracellular ROS generation. J Bone Miner Res 2006;21:1003-11.
13. Tasatargil A, Sadan G, Karasu E, Ozdem S. Changes in atrium and thoracic aorta reactivity to adenosinergic and adrenergic agonists in experimental hyperhomocysteinemia. J Cardiovasc Pharmacol 2006;47:673-9.
14. Durand P, Lussier-Cacan S, Blache D. Acute methionine load-induced hyperhomocysteinemia enhances platelet aggregation, thromboxane biosynthesis, and macrophage-derived tissue factor activity in rats. FASEB J 1997;11:1157-68.
15. Durand P, Fortin LJ, Lussier-Cacan S, Davignon J, Blache D. Hyperhomocysteinemia induced by folic acid deficiency and methionine load-applications of a modified HPLC method. Clin Chim Acta 1996;252:83-93.
16. Ungvari Z, Pacher P, Rischak K, Szollar L, Koller A. Dysfunction of nitric oxide mediation in isolated rat arterioles with methionine diet-induced hyperhomocysteinemia. Arterioscler Thromb Vasc Biol 1999;19:1899-904.
17. Gorski JP, Apone S, Shaffer KA, Batchelder A, Jean W, Williams JA, et al. Hypercalcemia during the osteogenic phase after rat marrow ablation coincides with increased bone resorption assessed by the NTx marker. Bone 2000;27:103-10.
18. Neuman RE, Logan MA. The determination of hydroxyproline. J Biol Chem 1950;184:299-306.
19. Elian KM. Plasma homocysteine and vascular disease. McGill J Med 1996;2:107-12.
20. Herrmann M, Kraenzlin M, Pape G, Sand-Hill M, Herrmann W. Relation between homocysteine and biochemical bone turnover markers and bone mineral density in peri- and postmenopausal women. Clin Chem Lab Med 2005;43:1118-23.
21. Golbahar J, Hamidi A, Aminzadeh MA, Omrani GR. Association of plasma folate, plasma total homocysteine, but not methylenetetrahydrofolate reductase C667T polymorphism, with bone mineral density in postmenopausal Iranian women: a cross-sectional study. Bone 2004;35:760-5.
22. Sato Y, Honda Y, Iwamoto J, Kanoko T, Satoh K. Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial. J Am Med Assoc 2005;293:1082-8.
23. Cagnacci A, Baldassari F, Rivolta G, Arangino S, Volpe A. Relation of homocysteine, folate, and vitamin B12 to bone mineral density of postmenopausal women. Bone 2003;33:956-9.
24. Delmas PD. Biochemical markers of bone turnover in osteoporosis. In: Riggs VL, Metton LJ, editors. Osteoporosis: etiology, diagnosis and management. New York: Raven Press; 1988. pp 297-316.
25. Miyao M, Morita H, Hosoi T, Kurihara H, Inoue S, Hoshino S, et al. Association of methylenetetrahydrofolate reductase (MTHFR) polymorphism with bone mineral density in postmenopausal Japanese women. Calcif Tissue Int 2000;66:190-4.
26. Bode MK, Laitinen P, Risteli J, Uusimaa P, Juvonen T. Atherosclerosis, type 1 collagen cross-linking and homocysteine. Atherosclerosis 2000;152:531-2.
27. Lubec B, Fang-Kircher S, Lubec T, Blom HJ, Boers GH. Evidence for McKusick's hypothesis of deficient collagen cross-linking in patients with homocystinuria. Biochim Biophys Acta 1996;1315:159-62.
28. Sakamotoa W, Isomuraa H, Fujiea K, Deyamab Y, Katoc A, Nishihirad J, et al. Homocysteine attenuates the expression of osteocalcin but enhances osteopontin in MC3T3-E1 preosteoblastic cells. Biochim Biophys Acta 2005;1740:12-16.
29. McKusick VA, editor. Heritable disorders of connective tissue. St. Louis, Mo.: C. V. Mosby; 1966.
30. Carmel R, Lau KH, Baylink DJ, Saxena S, Singer FR. Cobalamin and osteoblast-specific proteins. N Engl J Med 1988;319:70-5.
31. Kim GS, Kim CH, Park JY, Lee KU, Park CS. Effects of vitamin B-12 on cell proliferation and cellular alkaline phosphatase activity in human bone marrow stromal osteoprogenitor cells and UMR106 osteoblastic cells. Metabolism 1996;45:1443-6.
32. Iqbal MP, Ahmet M, Umer M, Mehboobali N, Qureshi AA. Effect of methotrexate and folinic acid on skeletal growth in mice. Acta Paediatr 2003;92:1438-44.
33. McFarlane SI, Muniyappa R, Shin JJ, Bahtiyar G, Sowers JR. Osteoporosis and cardiovascular disease: brittle bones and boned arteries, is there a link? Endocrine 2004;23:1-10.
34. Herrmann M, Stanger O, Paulweber B, Hufnagl C, Herrmann W. Folate supplementation does not affect biochemical markers of bone turnover. Clin Lab 2006;52:131-6.
35. Luckock M. Folic acid: nutritional biochemistry, molecular biology, and role in disease processes. Mol Genet Metab 2000;71:121-38.